Antleron’s Post

🌟 Exciting News Alert! 🌟 Thrilled to announce that Zuzanna Szklarz and Dominika Kulpińska will be representing ClinMark at the prestigious Swiss Biotech Day! 🇨🇭 Join us at our stand for engaging discussions, networking opportunities, and to explore the latest advancements in clinical research. See you there! #SwissBiotechDay #ClinMark #ClinicalResearch #Networking #IndustryInsights

Excited for the 7th Alcor Drug Discovery Platform Summit under the esteemed leadership of our Chairman for Day 1, Abdulkader Rahmo, who serves as President & CSO SMSbiotech. As we convene for this premier event, we embark on a collective journey of exploration, collaboration, and innovation in the dynamic realm of drug discovery. Under Chairman Rahmo's visionary guidance, this summit promises to be a nexus of cutting-edge research, insightful discussions, and invaluable networking opportunities. Join us as we unite with leading experts, industry pioneers, and visionaries to chart the course for the future of drug discovery. This summit isn't just about presentations—it's a convergence of minds dedicated to driving progress, shaping the future, and making a meaningful impact on global health. Let's elevate the discourse, ignite innovation, and propel the field of drug discovery to new heights. Together, we're shaping a healthier, brighter tomorrow. #AlcorDrugDiscovery #Summit #Innovation #ADDP2024 #DrugDiscovery #Preclinical #LifeSciencesSummits #DrugDiscovery #PreclinicalSummits #USADrugDiscoverySummits

So Many Conferences — So Little Time: Which Conference to Visit? I often get asked by companies and industry stakeholders which conferences they should visit or which are worth attending in the first half of the year. I have been in the circle for 25 years now and there is no straight answer. The standard response is, it depends on what you are looking for. If you are looking for general partnering, there are a number of big conferences like the "BIO International Convention" and "#bioeuropespring ", where you can meet people from all over the world. However, there are also some (smaller) regional-focused conferences like the "Swiss Biotech Day #swissbiotechday", which has grown to over 1,800 participants, or the "Asia Bio Partnering Forum #ASIABIO" and "BIO KOREA". There are also therapeutic or technology-focused conferences like "Advanced Therapies" in London, "Festival of Biologics" in San Diego, or "The World Vaccine Congress" in DC. If you are fundraising, there are options like the "BIO CEO & Investor Conference" in NY for more mature (public) companies, "RESI Conferences Life Science Nation (LSN)" (Atlanta and Barcelona) for earlier stage (private) companies, as well as "LSX World Congress" in London or "The Annual European Life Sciences CEO Forum #Sachs_ELSF" in Zurich. Additionally, different investment banks host conferences, of which "JPM JPMorgan Chase & Co." in San Francisco is where the industry meets. For very intimate interactions with other Biotech CEOs, I can recommend the "Biotech CEO Summit CEO Summit by Demy-Colton" in Barcelona and La Jolla. You can find all these conferences, along with their dates and links here » https://lnkd.in/dawnkF6p

Yesterday, Wednesday 23 October 2024, we held a productive follow-up Consortium Meeting at INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA (ICMAB-CSIC). It was a fantastic opportunity to review our progress, share insights, and discuss the next steps in our journey. Key highlights included updates and milestones on each work package, innovative solutions to enhance our impact and future planning to meet our deadlines and objectives on: ✅ Preclinical Development ✅ First-in-human trials ✅ Regulatory aspects and ethics ✅ Business Development ✅ Dissemination and Communication ✅ Project and data management A big thank you to all members for their dedication and hard work! Together, we are making significant strides toward the preclinical development of a nanomedicine candidate for Fabry rare disease treatment. Looking forward to our next meeting and continued success! 🚀 Nano4Rare is a project funded by the Strategic EIC Transition Challenges program from European Innovation Council and SMEs Executive Agency (EISMEA). #Nano4Rare #RareDiseases #Innovation #Healthcare #ClinicalTrials #ICMAB #CSIC #EuropeanProject #Collaboration #Innovation #ConsortiumMeeting Nora Ventosa, Enrique Vilalta, Guillem Vargas, Elisabet González, Judit Morlà, Judit Tomsen, Anna May

In 2024, we’ve seen a 60% reduction in clinical trial initiations compared to previous years, highlighting significant challenges in biotech R&D. Clinical trial starts have reverted to 2018 levels, underscoring the urgency of addressing these issues. Delaying decisions is not an option. To thrive in this environment, it’s essential to develop strategies to overcome funding challenges, manage the increasing “white space” between trial phases, and navigate the growing complexity of information requirements. Join the "Live and Learn - Navigating biotech's clinical development challenges: Diverse strategies for thriving in 2024’s complex landscape" session at BIO-Europe on November 5 at 9:00AM to gain evidence-based insights and hear from industry leaders on how they have tackled key challenges to navigate the current European landscape effectively. #BIOEurope #Biotech #Innovation #ClinicalDevelopment 

Clinical trial initiations in the biotech industry have reduced by 60% in 2024 and funding is still low compared to previous years. Emma Chaffin is hosting a session at #BioEurope to gain evidence-based insights from biotech leaders Anta Gkelou, Jennifer Schneider and Aneta Sottil. At BIO-Europe? Join the session and book a meeting to explore how to address the challenges in biotech's clinical development https://bit.ly/4fmOkl5

Also check out the poster sessions at BPI Europe in Vienna this week. There's a case study from BioPhorum #rawmaterials team members Benoit Mothes, Fabien ROUSSET and Ana Raquel Fortuna showcasing how they applied the principles from a recent BioPhorum publication* to 'Simplifying Technology Switches with a Quality-by-Design Approach to Protein A Registration' This case study highlights the power of industry collaboration between biomanufacturers and suppliers. #collaboration #acceleration #secondsourcing #biopharmaceuticals *BioPhorum approach to the registration of innovative raw materials using quality by design principles – Appendix 2: Protein A resins - BioPhorum Operations Group

Exciting News: Avelo Receives a 1.5M Innosuisse Grant!   Following the Eurostars grant in October, our portfolio company Avelo, a Swiss breath diagnostics start-up, has been awarded a CHF 1.5M Innosuisse Startup Innovation Project to further develop a new breath sampling device called AveloCollect.   This 34-month project leverages Avelo’s ongoing Eurostars project and will focus on clinical development and market readiness for AveloCollect. This device’s compatibility with various respiratory pathogens positions this product as a potential game changer for roll-out in European markets and offers opportunities for global commercial partnerships.   This is a significant step towards saving lives and reducing healthcare costs. 🎉🎉🎉   Read more here: https://lnkd.in/dn_Get63   Melanie Aregger, Tobias Broger; Innosuisse   #diagnostics #betterdiagnostics #makingadifference #aerosols #noninvasivesampling #breathtest #moleculardiagnostics #respiratoryinfections  

Are you interested in networking with peers and learning about #DrugDevelopment? There is STILL TIME to sign up for the BENELUX Drug Development Symposium 2.0 in Utrecht on 28 Nov. 2024. Where? Accelerator, Uppsalalaan 17, Utrecht Science Park, Netherlands Register here: https://gag.gl/WR2Ixf You will acquire new perspectives on pitching to investors, gain insights from biotech leaders on drug development, AI in clinical trials, and explore the role of innovation and technology in sustainability and global health equity. #biotech #innovation #clinicaltrials #healthequity #sustainability

This week is packed with insights and networking at the World Muscle Society Conference, BiotechX Europe, and much more! Both events emphasize the rapid advancements in biotech and pharma, especially in areas like neuromuscular diseases and cutting-edge innovation in healthcare. These conferences are crucial for staying ahead of industry trends, connecting with pioneers, and understanding how regulatory landscapes are evolving. For a recruiter like myself, specializing in Regulatory Affairs and Executive Search—these events are invaluable for staying on top of market trends, industry advancements, and purely networking. Exciting times for the industry and for those shaping its future! #WMS2024 #BiotechX #BiotechRecruitment #RegulatoryAffairs #PharmaLeadership #ExecutiveSearch